OmniaBio
Search results
Scope
Date
~
-
Bio & PharmaMedipost, OmniaBio to enhance cooperation for CDMO business
South Korea's stem-cell therapy company Medipost announced on Thursday that its Canadian affiliate OmniaBio made a two-day visit to South Korea on N...
Dec 01, 2022 (Gmt+09:00)
-
Bio & PharmaMedipost to expand CDMO business with 10 new clean rooms in Korea
Medipost Co, a South Korean biotechnology company, is expanding its cell and gene therapy contract development and manufacturing organization (CDMO)...
Oct 18, 2022 (Gmt+09:00)
-
Bio & PharmaMedipost acquires Canada’s OmniaBio for CDMO business
Medipost Co., a South Korean biotechnology company, has acquired a 39.6% stake in OmniaBio Inc., a Canada-based cell and gene therapy contract devel...
May 31, 2022 (Gmt+09:00)
1
